354 related articles for article (PubMed ID: 3177398)
1. Serum complement activation in central nervous system disease in Sjögren's syndrome.
Alexander EL; Provost TT; Sanders ME; Frank MM; Joiner KA
Am J Med; 1988 Oct; 85(4):513-8. PubMed ID: 3177398
[TBL] [Abstract][Full Text] [Related]
2. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
[TBL] [Abstract][Full Text] [Related]
3. Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients.
Govoni M; Bajocchi G; Rizzo N; Tola MR; Caniatti L; Tugnoli V; Colamussi P; Trotta F
Clin Rheumatol; 1999; 18(4):299-303. PubMed ID: 10468169
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
Alexander EL; Arnett FC; Provost TT; Stevens MB
Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
[TBL] [Abstract][Full Text] [Related]
5. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis.
Alexander EL
Rheum Dis Clin North Am; 1993 Nov; 19(4):869-908. PubMed ID: 8265827
[TBL] [Abstract][Full Text] [Related]
6. Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications.
Molina R; Provost TT; Alexander EL
Arthritis Rheum; 1985 Dec; 28(12):1341-7. PubMed ID: 3002396
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system disease in primary Sjögren's syndrome.
De Backer H; Dehaene I
Acta Neurol Belg; 1995; 95(3):142-6. PubMed ID: 7484051
[TBL] [Abstract][Full Text] [Related]
8. Immunological profiles determine neurological involvement in Sjögren's syndrome.
Jamilloux Y; Magy L; Hurtevent JF; Gondran G; de Seze J; Launay D; Ly KH; Lambert M; Hachulla E; Hatron PY; Vidal E; Fauchais AL
Eur J Intern Med; 2014 Feb; 25(2):177-81. PubMed ID: 24176941
[TBL] [Abstract][Full Text] [Related]
9. [Neurologic manifestations of primary Gougerot-Sjögren syndrome].
Lafitte C
Rev Neurol (Paris); 1998 Oct; 154(10):658-73. PubMed ID: 9846336
[TBL] [Abstract][Full Text] [Related]
10. Neurologic complications of primary Sjögren's syndrome.
Alexander EL; Provost TT; Stevens MB; Alexander GE
Medicine (Baltimore); 1982 Jul; 61(4):247-57. PubMed ID: 6283302
[TBL] [Abstract][Full Text] [Related]
11. Vasculitis in Sjögren's Syndrome.
Scofield RH
Curr Rheumatol Rep; 2011 Dec; 13(6):482-8. PubMed ID: 21870104
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in patients with primary Sjögren's syndrome: an indicator of systemic disease.
Lindgren S; Hansen B; Sjöholm AG; Manthorpe R
Autoimmunity; 1993; 16(4):297-300. PubMed ID: 8025208
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral neurological complications of primary Sjögren's syndrome.
Fauchais AL; Magy L; Vidal E
Presse Med; 2012 Sep; 41(9 Pt 2):e485-93. PubMed ID: 22840992
[TBL] [Abstract][Full Text] [Related]
14. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
15. [Vasculopathy in Sjögren's syndrome].
Feist E; Hermann KG; Dankof A
Z Rheumatol; 2009 Jun; 68(4):305-11. PubMed ID: 19357858
[TBL] [Abstract][Full Text] [Related]
16. Nervous system manifestations in Sjögren's syndrome.
Hietaharju A; Yli-Kerttula U; Häkkinen V; Frey H
Acta Neurol Scand; 1990 Feb; 81(2):144-52. PubMed ID: 2327235
[TBL] [Abstract][Full Text] [Related]
17. Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
Sanders ME; Alexander EL; Koski CL; Shin ML; Sano Y; Frank MM; Joiner KA
Ann N Y Acad Sci; 1988; 540():387-8. PubMed ID: 3207265
[No Abstract] [Full Text] [Related]
18. Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.
Asherson RA; Fei HM; Staub HL; Khamashta MA; Hughes GR; Fox RI
Ann Rheum Dis; 1992 Apr; 51(4):495-8. PubMed ID: 1586247
[TBL] [Abstract][Full Text] [Related]
19. Primary Sjögren's syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis.
Ferreiro JE; Robalino BD; Saldana MJ
Am J Med; 1987 Jun; 82(6):1227-32. PubMed ID: 3605139
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome. Association of cutaneous vasculitis with central nervous system disease.
Alexander E; Provost TT
Arch Dermatol; 1987 Jun; 123(6):801-10. PubMed ID: 3555358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
